Forschung
Lehre
Lösungen
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Radboud Institute for Molecular Life Sciences,
Department of Pathology,
Radboud Institute for Molecular Life Sciences, Department of Pathology
Jennifer Eymael has not added Biography.
If you are Jennifer Eymael and would like to personalize this page please email our Author Liaison for assistance.
Origin and fate of the regenerating cells of the kidney.
European journal of pharmacology Nov, 2016 | Pubmed ID: 27448504
Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells.
European journal of pharmacology Feb, 2017 | Pubmed ID: 28012971
CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.
Kidney international 03, 2018 | Pubmed ID: 29276101
Inhibition of mTOR delayed but could not prevent experimental collapsing focal segmental glomerulosclerosis.
Scientific reports May, 2020 | Pubmed ID: 32444668
Radboud university medical center
Jennifer Eymael1,
Laura Miesen1,
Fieke Mooren1,
Jitske Jansen1,2,
Jack Wetzels3,
Johan van der Vlag4,
Bart Smeets1
1Radboud Institute for Molecular Life Sciences, Department of Pathology, Radboud University Medical Center,
2Radboud Institute for Molecular Life Sciences, Amalia Children's Hospital, Department of Paediatric Nephrology, Radboud University Medical Center,
3Radboud Institute for Health Sciences, Department of Nephrology, Radboud University Medical Center,
4Radboud Institute for Molecular Life Sciences, Department of Nephrology, Radboud University Medical Center
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten